Cargando…

Proteomic differences among patients with heart failure taking furosemide or torsemide

BACKGROUND: Loop diuretics are commonly used for patients with heart failure (HF) but it remains unknown if one loop diuretic is clinically superior. HYPOTHESIS: Biomarkers and proteomics provide insight to how different loop diuretics may differentially affect outcomes. METHODS: Blood and urine wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Lauren B., Bruce, Scott, Psotka, Mitchell, Mentz, Robert, Bell, Rachel, Seliger, Stephen L., O'Connor, Christopher, deFilippi, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922525/ https://www.ncbi.nlm.nih.gov/pubmed/35014074 http://dx.doi.org/10.1002/clc.23733

Ejemplares similares

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

Evaluation of the short‐term echocardiographic effects of two loop diuretics, furosemide and torsemide, in a group of dogs
por: Hosseini, Farzaneh, et al.
Publicado: (2023)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

A case of bullous pemphigoid induced by torsemide
por: Wurtz, Paul, et al.
Publicado: (2022)

Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19
por: Abraham, William T., et al.
Publicado: (2020)

Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19
por: Abraham, William T., et al.
Publicado: (2020)

Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015)

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population
por: Parikh, Ravi H., et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic properties of orally administered torsemide in healthy horses
por: Agne, Gustavo F., et al.
Publicado: (2018)

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action
por: Shah, Salim, et al.
Publicado: (2017)

Mortality in Elderly Patients Taking Furosemide: Prospective Cohorts Study
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2022)

Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis
por: Bakhshi, Hooman, et al.
Publicado: (2023)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

A Life-Threatening Case of Torsemide-Induced Toxic Epidermal Necrolysis Associated With the Treatment of Anasarca
por: Reddy, Sujana, et al.
Publicado: (2022)

Long‐term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration
por: Adin, D., et al.
Publicado: (2017)

Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials
por: Fiuzat, Mona, et al.
Publicado: (2022)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

A Simplified HPLC Method for Quantification of Torsemide from Human Plasma and its Application to a Bioequivalence Study
por: Khan, I. J., et al.
Publicado: (2008)

Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy
por: Truby, Lauren K., et al.
Publicado: (2021)

Effect of aliskiren, telmisartan and torsemide on cardiac dysfunction in l-nitro arginine methyl ester (l-NAME) induced hypertension in rats
por: Sadek, Sawsan A., et al.
Publicado: (2015)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
por: Suthahar, Navin, et al.
Publicado: (2020)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
por: Brennecke, Anja, et al.
Publicado: (2020)

Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4
por: Minciunescu, Andrei, et al.
Publicado: (2022)

Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection Fraction
por: Sharma, Abhinav, et al.
Publicado: (2022)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Furosemide: No effect: case report
Publicado: (2020)

Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
por: Meersch, Melanie, et al.
Publicado: (2023)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Cellular Proteomes Drive Tissue-Specific Regulation of the Heat Shock Response
por: Ma, Jian, et al.
Publicado: (2017)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_frm9tvfmg3p7t201v5g2o0sqh9